|
End-of-day quote
Other stock markets
|
||
| - CHF | - |
|
| 07-23 | GE HealthCare says CFO Saccaro to step down; reports preliminary Q2 results | RE |
| 07-23 | AI shortens drug discovery to around 1 year in China, Insilico CEO says | RE |
| Market Cap | 141B 124B 115B 106B 198B 13,484B 201B 1,368B 534B 6,658B 528B 516B 23,013B | P/E 2026 * |
12.5x | P/E 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise Value | 190B 167B 155B 143B 268B 18,218B 272B 1,848B 722B 8,996B 713B 698B 31,092B | EV / Sales 2026 * |
3.08x | EV / Sales 2027 * | 3.1x |
| Free-Float |
59.06% | Yield 2026 * |
6.98% | Yield 2027 * | 7.05% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
David Denton
DFI | Director of Finance/CFO | 60 | 2022-05-01 |
| Chief Tech/Sci/R&D Officer | - | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | +4.41% | +47.35% | +163.20% | 1,068B | |
| +0.97% | +6.88% | +58.02% | +53.12% | 641B | |
| -0.94% | +1.39% | +35.02% | +72.60% | 454B | |
| +0.53% | +8.21% | +38.60% | +34.08% | 351B | |
| +0.50% | +2.69% | +38.12% | +42.85% | 299B | |
| -0.80% | +2.11% | +18.22% | +15.36% | 266B | |
| +0.50% | +1.31% | -27.23% | -37.87% | 220B | |
| +0.06% | +3.32% | +22.73% | +59.40% | 203B | |
| +0.94% | -2.02% | +12.32% | +70.59% | 162B | |
| Average | +0.64% | +2.76% | +27.02% | +52.59% | 407.04B | |
| Weighted average by Cap. | +0.92% | +2.85% | +36.60% | +77.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.74B 54.28B 50.53B 46.4B 87.13B 5,921B 88.28B 601B 235B 2,924B 232B 227B 10,105B | 59.37B 52.19B 48.58B 44.62B 83.78B 5,693B 84.88B 577B 226B 2,811B 223B 218B 9,716B |
| Net income | 10.63B 9.35B 8.7B 7.99B 15.01B 1,020B 15.2B 103B 40.39B 504B 39.92B 39.05B 1,740B | 10.28B 9.04B 8.41B 7.73B 14.51B 986B 14.7B 99.99B 39.05B 487B 38.59B 37.76B 1,682B |
| Net Debt | 49.36B 43.4B 40.4B 37.1B 69.66B 4,734B 70.58B 480B 188B 2,338B 185B 181B 8,079B | 43.17B 37.95B 35.32B 32.44B 60.92B 4,140B 61.72B 420B 164B 2,044B 162B 159B 7,065B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
